Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

acadia pharmaceuticals

POPULAR ARTICLES

Pharma Market Update: Q3 2019 in Review

pharmaceutical investing

Pharma Market Update: Q3 2019 in Review

ACADIA Pharmaceuticals Announces Positive Top-line Results from Phase 2 CLARITY Trial

pharmaceutical investing

ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement

LATEST ARTICLES

Pharmaceutical Investing

pharmaceutical investing

Pharmaceutical Update: Q2 2018 in Review

pharmaceutical investing

ACADIA Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for NUPLAZID (Pimavanserin)

ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients

ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation

Biotech Investing

What are the 5 Top Holdings in the SPDR S&P Biotechnology ETF?

Biotech Investing

5 Top NASDAQ Biotech Stocks: 5 Companies Gain over 30 Percent Last Week

Latest News

Lithium Africa: Searching for Low-cost, Marquee Hardrock in Africa

Nuvau Minerals Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

Blue Lagoon Resources to Participate in Canada's Premier Mining Investor Conference in Quebec City

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders

Silver Stocks and the Land Grab for Silver Assets